Breast cancer drug Supinoxin shows potential for small-cell lung cancer in new tests
PICR researchers have identified Supinoxin, a small-molecule drug, as a potential new therapy for small-cell lung cancer (SCLC), one of the most aggressive and difficult-to-treat cancers.
Research
Give Now
Events
Tyler Trent Pediatric Cancer Research Center
In creating the Tyler Trent Pediatric Cancer Research Center, the Purdue Institute for Cancer Research (PICR) brings together deep strengths in multiple research fields to fight pediatric cancers and to beat osteosarcoma, the rare bone cancer that took the life of beloved Purdue alumnus Tyler Trent.
Tyler’s parents, Tony and Kelly Trent, lead the way with their gift of $100,000 to continue the fight against cancer that Tyler began. To join in the fight, you can donate here to the center’s life-sustaining research.
Indiana research leads to life-extending treatment for prostate cancer
A collaboration between the Purdue Institute for Cancer Research and the IU Simon Comprehensive Cancer Center has helped deliver a life-extending therapy for patients with advanced prostate cancer.
Pluvicto™ — a targeted radiopharmaceutical therapy invented by Purdue researcher Philip Low and tested in clinical trials at Indiana University — is now giving patients like U.S. Army veteran Don Bryant new hope and time.
